Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
F
Founti, P., Haidich A-B., Chatzikyriakidou A., Salonikiou A., Anastasopoulos E., Pappas T., et al. (2015).  Ethnicity-Based Differences in the Association of LOXL1 Polymorphisms with Pseudoexfoliation/Pseudoexfoliative Glaucoma: A Meta-Analysis.. Ann Hum Genet. 79(6), 431-50.
Founti, P., Topouzis F., van Koolwijk L., Traverso C. E., Pfeiffer N., & Viswanathan A. C. (2009).  Biobanks and the importance of detailed phenotyping: a case study--the European Glaucoma Society GlaucoGENE project.. Br J Ophthalmol. 93(5), 577-81.
Fountoulakis, K. N., Gonda X., Vieta E., & Schmidt F. (2009).  Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis.. Ann Gen Psychiatry. 8, 27.
Fountoulakis, K. N., & Möller H-J. (2011).  Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data.. Int J Neuropsychopharmacol. 14(3), 405-12.
Fountoulakis, K. N., Moeller H-J., Kasper S., Tamminga C., Yamawaki S., Kahn R., et al. (2020).  The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia.. CNS Spectr. 1-25.
Fountoulakis, K. N., Gonda X., Andreoulakis E., Fokas K., & Iacovides A. (2013).  No differences between drug naive and drug experienced unipolar depressed patients in terms of neurobiological testing: a cross sectional study.. J Psychiatr Res. 47(12), 1984-90.
Fountoulakis, K. N., Karavelas V., Moysidou S., Mavridis D., Pastiadis K., Petalidou N., et al. (2019).  Efficacy of Add-on Pregabalin in the Treatment of Patients with Generalized Anxiety Disorder and Unipolar Major Depression With an Early Nonresponse to Escitalopram: A Double-Blind Placebo-Controlled Study.. Pharmacopsychiatry. 52(4), 193-202.
Fountoulakis, K. N., & Möller H-J. (2012).  Antidepressant drugs and the response in the placebo group: the real problem lies in our understanding of the issue.. J Psychopharmacol. 26(5), 744-50.
Fountoulakis, K. N. (2020).  Brain Volume Changes Under Treatment With Antipsychotics.. JAMA Psychiatry. 77(8), 876-877.
Fountoulakis, K. N., Panagiotidis P., Kimiskidis V., Nimatoudis I., & Gonda X. (2019).  Neurological soft signs in familial and sporadic schizophrenia.. Psychiatry Res. 272, 222-229.
Fountoulakis, K. N. (2017).  DSM-III-R change in definition might have affected placebo response to antidepressants.. Lancet Psychiatry. 4(1), 21-22.
Fountoulakis, K. N., Balaris D., Nikolaou V., & Νimatoudis J. (2016).  [Non-conventional pharmacological agents for the treatment of bipolar disorder: Α systematic review of the evidence].. Psychiatriki. 27(4), 253-263.
Fountoulakis, K. N., Siamouli M., Magiria M., Pantoula E., Moutou K., Kemeridou M., et al. (2014).  Standardization of the TEMPS-A in the Greek general population.. J Affect Disord. 158, 19-29.
Fountoulakis, K. N., Yatham L. N., Grunze H., Vieta E., Young A. H., Blier P., et al. (2020).  The CINP Guidelines on the Definition and Evidence-Based Interventions for Treatment-Resistant Bipolar Disorder.. Int J Neuropsychopharmacol. 23(4), 230-256.
Fountoulakis, K. N., Panagiotidis P., Gonda X., Kimiskidis V., & Nimatoudis I. (2019).  Corrigendum to "Neurological soft signs significantly differentiate schizophrenia patients from healthy controls"; [Acta Neuropsychiatrica 2018;30(2):97-105].. Acta Neuropsychiatr. 31(1), 61.
Fountoulakis, K. N., Panagiotidis P., Theofilidis A. T., & Nimatoudis I. (2020).  One-year Outcome of First vs. Later Episode Schizophrenia: A Real-world Naturalistic Study.. Clin Psychopharmacol Neurosci. 18(3), 434-444.
Fountoulakis, K. N. (2015).  Treatment guidelines for mental disorders: reality or illusion?. Psychiatriki. 26(2), 89-92.
Fountoulakis, K. N., Pavlidis I., & Tsolaki M. (2011).  Life events and dementia: what is the nature of their relationship?. Psychiatry Res. 190(1), 156-8.
Fountoulakis, K. N., & Souliotis K. (2019).  The right to choose treatment-without-treatment: respecting civil rights or an unprecedented manifestation of 'reverse stigma'?. Acta Neuropsychiatr. 31(1), 56-58.
Fountoulakis, K. N. (2012).  Past, present and future in the treatment of major psychotic disorders.. Curr Pharm Des. 18(12), 1557.
Fountoulakis, K. N., Savopoulos C., Zannis P., Apostolopoulou M., Fountoukidis I., Kakaletsis N., et al. (2016).  Climate change but not unemployment explains the changing suicidality in Thessaloniki Greece (2000-2012).. J Affect Disord. 193, 331-8.
Fountoulakis, K. N., Vieta E., & Schmidt F. (2011).  Aripiprazole monotherapy in the treatment of bipolar disorder: a meta-analysis.. J Affect Disord. 133(3), 361-70.
Fountoulakis, K. N., Koupidis S. A., Grammatikopoulos I. A., & Theodorakis P. N. (2013).  First reliable data suggest a possible increase in suicides in Greece.. BMJ. 347, f4900.
Fountoulakis, K. N. (2010).  Disruption of biological rhythms as a core problem and therapeutic target in mood disorders: the emerging concept of 'rhythm regulators'.. Ann Gen Psychiatry. 9, 3.
Fountoulakis, K. N., Yatham L., Grunze H., Vieta E., Young A., Blier P., et al. (2017).  The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.. Int J Neuropsychopharmacol. 20(2), 121-179.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές